nocodazole has been researched along with Cancer of Pancreas in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parsels, LA | 1 |
Tanska, DM | 1 |
Parsels, JD | 1 |
Zabludoff, SD | 1 |
Cuneo, KC | 1 |
Lawrence, TS | 1 |
Maybaum, J | 1 |
Morgan, MA | 1 |
Farshori, PQ | 1 |
Goode, D | 1 |
Gansauge, S | 1 |
Nussler, AK | 1 |
Beger, HG | 1 |
Gansauge, F | 1 |
3 other studies available for nocodazole and Cancer of Pancreas
Article | Year |
---|---|
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry.
Topics: Antimetabolites, Antineoplastic; Cell Cycle Checkpoints; Cell Line, Tumor; Checkpoint Kinase 1; Cycl | 2016 |
Effects of the microtubule depolymerizing and stabilizing agents Nocodazole and taxol on glucose-induced insulin secretion from hamster islet tumor (HIT) cells.
Topics: Adenoma, Islet Cell; Animals; Colforsin; Cricetinae; Fluorescent Antibody Technique; Glucose; Insuli | 1994 |
Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Topics: Apoptosis; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; G1 Phase; Humans; Inte | 1998 |